**Abstract**

**Background:** Prescription/use of antipsychotic drugs (APDs) in children is increasing rapidly worldwide, despite serious limitations in the safety and efficacy of APD use on the developing brain. Whilst APDs are known to have a high affinity for dopamine (DA) receptors to produce therapeutic effects, DA receptors are also involved in critical neurodevelopmental processes. This study investigated the long-term effects of childhood/adolescent APD use on DA receptors in adult brains.

***Methods:*** Male and female rats (n=6/group) were treated with Aripiprazole (1 mg/kg), Olanzapine (1 mg/kg) and Risperidone (0.3 mg/kg), 3 times/day from postnatal day (PD) 22--50. Animals were sacrificed on PD106. Levels of DA D~1~R and D~2~R were investigated via quantitative autoradiographic and western blot techniques.

***Results:*** In comparison to controls, D~1~R protein levels were significantly decreased following Risperidone treatment in the nucleus accumbens (NAc) of male rats (p\<0.01), and Aripiprazole treatment in the ventral tegmental area of females (p\<0.001). Furthermore, D~2~R levels were increased in the prefrontal cortex of female rats (p\<0.05), with a trend to decrease in the Hippocampus of males (p=0.099).

Trends to significant increases of D~1~R and D~2~R bindings were found in female rats. In comparison to controls, Risperidone increased D~1~R binding in the Hippocampus (p=0.077), whilst Olanzapine increased D~2~R binding in the NAc (p=0.054).

***Conclusions:*** Long-term changes to D~1~R and D~2~R were uncovered following childhood/adolescent APD treatment, indicating the potential long-term effects of APD use on the DA neurotransmitter system during the critical neurodevelopmental window. Furthermore, differing effects of childhood APD treatment on D~1~R and D~2~R were found across both genders and APD treatment groups. Further investigations into the neural mechanisms involved for observed differences across drug treatment groups may shed further light on potential chronic effects of APD in the young population. *(M. De Santis was supported by an Australian Rotary Health scholarship).*
